2664
Kawachi Pharmaceutical Co., Ltd.
2026/01/27
For the 3rd quarter of the fiscal year ending March 2026, net sales were ¥214.986 billion (0.9% decrease YoY), operating income was ¥4.623 billion (20.0% decrease YoY), and net income attributable to owners of parent was ¥3.465 billion (13.1% decrease YoY).
